Table 5 Associations between myositis autoantibodies and clinical subsets
| Â | Anti-ARS | Anti-p140 | Anti-p155/140 | Anti-Mi2 | Total |
|---|---|---|---|---|---|
| Â | n = 6 | n = 9 | n = 8 | n = 7 | n = 49 |
ILD | 5 | 6 | 0 | 0 | 14 |
   Rapidly progressive ILD | 0 | 4 |  |  | 4 |
Cancer-associated myositis | 3 | 0 | 5 | 1 | 11 |
Mortality | 2 | 3 | 4 | 0 | 10 |
   ILD-related | 0 | 3 | 0 | 0 | 3 |
   Cancer-related | 1 | 0 | 4 | 0 | 6 |